ASP Isotopes (NASDAQ:ASPI) Posts Earnings Results, Misses Estimates By $0.13 EPS

ASP Isotopes (NASDAQ:ASPI – Get Free Report) released its earnings results on Monday. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.13), FiscalAI reports. ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%. The firm had revenue of $5.12 million during the quarter, compared to analysts’ expectations of $5.68 million.

ASP Isotopes Price Performance

Shares of NASDAQ:ASPI traded down $0.20 during trading on Monday, hitting $1.54. 4,475,844 shares of the company’s stock were exchanged, compared to its average volume of 4,713,274. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85. ASP Isotopes has a 52-week low of $1.53 and a 52-week high of $8.60. The business’s 50-day simple moving average is $2.57 and its 200 day simple moving average is $4.59. The company has a market cap of $236.10 million, a price-to-earnings ratio of -1.17 and a beta of 3.77.

Insiders Place Their Bets

In other ASP Isotopes news, CEO Paul Mann sold 83,759 shares of the company’s stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $4.10, for a total value of $343,411.90. Following the completion of the transaction, the chief executive officer directly owned 9,328,570 shares in the company, valued at $38,247,137. This represents a 0.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John Ryan acquired 15,000 shares of the business’s stock in a transaction on Wednesday, September 30th. The shares were bought at an average cost of $2.68 per share, with a total value of $40,200.00. Following the completion of the acquisition, the director owned 675,222 shares in the company, valued at approximately $1,809,594.96. This represents a 2.27% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders sold a total of 245,285 shares of company stock worth $899,887 over the last quarter. Company insiders own 14.40% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, September 21st. Wall Street Zen upgraded shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 22nd. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, ASP Isotopes currently has a consensus rating of “Hold” and a consensus price target of $12.00.

Check Out Our Latest Stock Analysis on ASPI

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc. is an advanced materials company focused on producing and commercializing enriched isotopes. Its proprietary Aerodynamic Separation Process is designed to separate isotopes and support production across a range of applications. The company’s targeted products include isotopes used in medical imaging and pharmaceuticals, semiconductor manufacturing, quantum technologies and nuclear energy. Examples include molybdenum-100, silicon-28 and ytterbium-176. ASP Isotopes is headquartered in the United States and has pursued isotope-enrichment operations in South Africa.

Read More

Earnings History for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.